(VIANEWS) – Putnam Managed Municipal Income Trust (PMM), Public Service Enterprise Group (PEG), Clorox Company (CLX) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Putnam Managed Municipal Income Trust (PMM) | 4.7% | 2024-04-06 21:07:09 |
| Public Service Enterprise Group (PEG) | 3.73% | 2024-04-12 15:21:55 |
| Clorox Company (CLX) | 3.08% | 2024-04-12 15:19:16 |
| Merck (MRK) | 2.49% | 2024-04-14 03:13:14 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Putnam Managed Municipal Income Trust (PMM) – Dividend Yield: 4.7%
Putnam Managed Municipal Income Trust’s last close was $5.90, 8.1% below its 52-week high of $6.42. Intraday change was -0.67%.
Putnam Managed Municipal Income Trust is a close-ended fixed income mutual fund launched and managed by Putnam Investment Management LLC. It is co-managed by Putnam Investments Limited. The fund invests in the fixed income markets of the United States. It primarily invests in a diversified portfolio of tax-exempt municipal securities, including high-yield securities that are rated below investment grade. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. Putnam Managed Municipal Income Trust was formed on February 24, 1989 and is domiciled in the United States.
Earnings Per Share
As for profitability, Putnam Managed Municipal Income Trust has a trailing twelve months EPS of $0.23.
PE Ratio
Putnam Managed Municipal Income Trust has a trailing twelve months price to earnings ratio of 25.65. Meaning, the purchaser of the share is investing $25.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.25%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.4%, now sitting on 19.31M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 23, 2024, the estimated forward annual dividend rate is 0.29 and the estimated forward annual dividend yield is 4.7%.
Moving Average
Putnam Managed Municipal Income Trust’s value is under its 50-day moving average of $6.12 and above its 200-day moving average of $5.87.
More news about Putnam Managed Municipal Income Trust.
2. Public Service Enterprise Group (PEG) – Dividend Yield: 3.73%
Public Service Enterprise Group’s last close was $65.87, 0.43% higher than its 52-week high of $65.59. Intraday change was -0.87%.
Public Service Enterprise Group Incorporated, through its subsidiaries, operates in electric and gas utility business in the United States. It operates through PSE&G and PSEG Power segments. The PSE&G segment transmits electricity; distributes electricity and natural gas to residential, commercial, and industrial customers; and appliance services and repairs to customers through its service territory, as well as invests in solar generation projects, and energy efficiency and related programs. The PSEG Power segment engages in nuclear generation businesses; and supplies power and natural gas to nuclear power plants and gas storage facilities activities. As of December 31, 2023, it had electric transmission and distribution system of 25,000 circuit miles and 866,600 poles; 56 switching stations with an installed capacity of 39,953 megavolt-amperes (MVA), and 235 substations with an installed capacity of 10,382 MVA; 109 MVA aggregate installed capacity for substations; four electric distribution headquarters and five electric sub-headquarters; 18,000 miles of gas mains, 12 gas distribution headquarters, two sub-headquarters, and one meter shop, as well as 56 natural gas metering and regulating stations; and 158 MegaWatts defined conditions of installed PV solar capacity. Public Service Enterprise Group Incorporated was founded in 1903 and is based in Newark, New Jersey.
Earnings Per Share
As for profitability, Public Service Enterprise Group has a trailing twelve months EPS of $5.13.
PE Ratio
Public Service Enterprise Group has a trailing twelve months price to earnings ratio of 12.84. Meaning, the purchaser of the share is investing $12.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.55%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 17%, now sitting on 11.24B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Public Service Enterprise Group’s EBITDA is 4.66.
More news about Public Service Enterprise Group.
3. Clorox Company (CLX) – Dividend Yield: 3.08%
Clorox Company’s last close was $141.98, 20.33% below its 52-week high of $178.21. Intraday change was -1.95%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. It sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
Earnings Per Share
As for profitability, Clorox Company has a trailing twelve months EPS of $0.64.
PE Ratio
Clorox Company has a trailing twelve months price to earnings ratio of 221.84. Meaning, the purchaser of the share is investing $221.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.23%.
More news about Clorox Company.
4. Merck (MRK) – Dividend Yield: 2.49%
Merck’s last close was $125.74, 3.46% below its 52-week high of $130.24. Intraday change was -0.33%.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Earnings Per Share
As for profitability, Merck has a trailing twelve months EPS of $0.14.
PE Ratio
Merck has a trailing twelve months price to earnings ratio of 898.14. Meaning, the purchaser of the share is investing $898.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.9%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Merck’s stock is considered to be overbought (>=80).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Merck’s EBITDA is 5.67.
Yearly Top and Bottom Value
Merck’s stock is valued at $125.74 at 20:15 EST, under its 52-week high of $130.24 and way above its 52-week low of $99.14.
More news about Merck.
